about
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeLung cancer incidence in never smokersBreast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999.Impact of intercensal population projections and error of closure on breast cancer surveillance: examples from 10 California counties.Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysisEtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSProposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction IntervalsExisting data on breast cancer in African-American women: what we know and what we need to know.Population-based surveillance of HIV-associated cancers: utility of cancer registry data.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors.Disparities in mammographic screening for Asian women in California: a cross-sectional analysis to identify meaningful groups for targeted intervention.Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status.Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study.Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.Adenomyosis and endometriosis in the California Teachers StudyMelanoma underreporting: why does it happen, how big is the problem, and how do we fix it?Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers StudyAre cancer registries unconstitutional?Racial and social class gradients in life expectancy in contemporary California.Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics.Increasing burden of melanoma in the United States.Lung Cancer Survival Among Chinese Americans, 2000 to 2010.Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohortDifferences in marital status and mortality by race/ethnicity and nativity among California cancer patients.Disparities in survival after Hodgkin lymphoma: a population-based studyBreast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave.Parents' ages at birth and risk of adult-onset hematologic malignancies among female teachers in CaliforniaMeat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study.Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
P50
Q21195226-9A8E1D49-1A8D-40FA-AA3E-0FCD3735DA7DQ23913478-5FC8A92E-46EB-4873-A8AF-A48AC4B78A27Q24800007-B7BCCE98-321D-4681-853A-596672CA37DCQ24813475-E441C1D0-90D1-4DB7-85C9-2ADBBD44A599Q27336142-F0105D95-4167-4DA2-8BD5-6CCCA083287BQ28393769-CCC6D972-B7FA-4ABB-BDFF-3A8BAE48894AQ28584533-F6D980B2-B0D9-4851-950C-043C60E1E0EAQ30479763-6E8DD886-CFF7-4DFC-8057-170D265F575AQ30541098-76189E3C-FD4A-46A4-8A8E-1F21337022F1Q30581482-36B5FBC4-8E45-444A-B759-6B0C2187A9FAQ30665329-00F63C50-A37A-466A-A575-B7A194C132D0Q30749748-133908B7-6472-4081-8A75-6D2E3D073662Q30756790-5B9744E8-6FD5-4872-80B9-7767704D16D9Q30942871-75AF85D9-AF0A-4F1E-ADD4-3E1B484B18A5Q31082788-38BCC0C5-0813-47FF-946F-A168D69A7CA5Q33248076-461E5C8F-D852-4D70-A857-C773D75D4954Q33303945-7C712A97-321A-4364-8A0D-053D2B32D48BQ33475114-624E1200-E51B-45E8-A19B-D2B8E7D9AF15Q33517115-DF243876-C2F0-40B0-8E30-19EC2ACDA8E2Q33569338-324635E2-E771-4DF4-9B18-C4EE3E002A7BQ33619700-0F310FC2-533F-40C8-A356-BFBD72780AC9Q33619769-AD1D4399-51BD-4B22-8952-64BA556CFF14Q33622966-CFFBA6ED-5D59-49D6-9F18-311689FF46A5Q33693138-FE635DFB-41F1-42A0-9B17-E02462E2BE29Q33709421-A2C0E2EC-3DF8-4873-A31B-68F6E1300B7BQ33718809-3F4F194C-29C6-4A4B-8430-EC00C5654FB8Q33741434-B3C92F21-9388-4C4A-9A5F-1BE92CE6BA0FQ33770853-AF525C42-95F6-46B2-B456-6FB5056965B5Q33770870-30A3D551-1E0E-44E4-A25F-4E5BB8665889Q33807871-917634B3-F928-49FC-9947-5AB7571E669DQ33836015-4181714F-0DA6-4EFD-9F09-87C83E3DD99FQ33873198-97074FB9-DCD1-4BC1-8756-C7C941243EC5Q33892873-BE826643-7950-4937-9194-CEBE7BC67CFFQ33924837-869C0DD0-A8A1-4014-BE8D-FDBAFD8908FCQ33925220-EA210F62-EA7C-48B0-9B7A-1E4844DDAED1Q33955302-3DF4B4A0-CF49-40CC-B52B-9C13ADD57F0DQ34041780-701F1F47-C4AC-4874-9253-80E3245B5CAAQ34097339-91AA4C9C-AC1A-4E37-B25D-D45C2FC5E237Q34115930-142ADA5E-1D6B-410D-8F00-450EF7D20E2EQ34137880-5F6344D1-0A8D-4EE1-B1CB-52605E231630
P50
description
researcher ORCID ID = 0000-0002-7515-2549
@en
wetenschapper
@nl
name
Christina A Clarke
@ast
Christina A Clarke
@en
Christina A Clarke
@nl
type
label
Christina A Clarke
@ast
Christina A Clarke
@en
Christina A Clarke
@nl
prefLabel
Christina A Clarke
@ast
Christina A Clarke
@en
Christina A Clarke
@nl
P21
P31
P496
0000-0002-7515-2549